Day Zero Diagnostics — which seeks to harness whole-genome sequencing and AI in the fight against antibiotic-resistant infections — announced today that it has successfully wrapped up a $16M financing round. The latest round raises the Boston-based company’s venture capital funding total to $49M, coupled with over $18M in non-dilutive funding. “This funding is a […]
MassDevice Earnings Roundup
Medtronic pleased with Diabetes progress as new CGM’s FDA review ‘is progressing’
After ending fiscal 2023 on a high, the Diabetes unit at Medtronic continues to roll on into the company’s new fiscal year. To finish fiscal 2023 (in April), Medtronic received FDA approval for its next-generation MiniMed 780G automated insulin delivery system. Shortly after, the company fully resolved a warning letter issue with the FDA. Medtronic […]
Medtronic stock rises on strong Q1 results, increased guidance
Medtronic shares ticked up today on first-quarter results that came in ahead of the consensus forecast. The company reported growth stemming from its Diabetes and Cardiac Rhythm business units, while it also reported sustained progress with its Hugo surgical robot. Shares of MDT rose 3.6% at $84.55 apiece in early-morning trading today. MassDevice’s MedTech 100 […]
Asensus Surgical targets FDA clearance for Luna surgical robot in 2025
Asensus Surgical (NYSE:ASXC) announced its second-quarter financial results and shared an update on its Luna surgical robot platform. Shares of ASXC rose 9.8% at 36¢ apiece in late-afternoon trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — stayed even. Research Triangle Park, North Carolina-based Asensus unveiled […]
ReWalk stock dips on Q2 EPS miss
ReWalk Robotics (Nasdaq:RWLK) shares fell today on second-quarter results that came in mixed compared to the consensus forecast. Shares of RWLK dipped 1.8% at 71¢ apiece in mid-afternoon trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — remained even. The Yokneam Illit, Israel-based company posted losses […]
Senseonics posts mixed Q2 results, submits to FDA for iCGM designation
Senseonics (NYSE:SENS) shares took a hit today on second-quarter results that missed the consensus sales forecast. Shares of SENS fell nearly 12% at 65¢ apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — stayed relatively even. The Germantown, Maryland-based implantable continuous glucose monitor […]
Insulet raises 2023 guidance with Omnipod sales up 33%
Insulet stock is down today, even with Street-beating Q2 results and raised guidance. Shares of PODD were down more than 3% at $229.85 apiece by midday trading today. (Insulet announced its earnings yesterday evening.) MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down slightly. The Acton, […]
Masimo ‘disappointed’ in Q2 results, confirms slashed guidance
Masimo shares fell this morning after the company shared second-quarter results that included reduced 2023 guidance. Shares of MASI were down more than 2% at $117.11 apiece. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down slightly. The guidance cut comes as no surprise after the […]
Orthofix beats The Street in Q2, upping full-year guidance
Orthofix Medical posted second-quarter results this evening that beat the consensus forecast on Wall Street. It also raised its revenue and adjusted EBITDA guidance for the rest of the year, reflecting positive developments in Bone Growth Therapies and other sectors. It’s been more than eight months since Orthofix’s merger with SeaSpine. The Lewisville, Texas–based orthopedic […]
Acutus posts Q2 beats, expects AcQBlate ablation catheter approval by end of 2023
Acutus Medical (Nasdaq:AFIB) reported positive second-quarter results, with some future plans that got analysts excited. Shares of AFIB rose 0.8% at 68¢ apiece in mid-afternoon trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — fell 2.1%. BTIG analysts Marie Thibault and Sam Eiber maintained a “Buy” […]
Embecta increases 2023 guidance, reports closed-loop insulin delivery tech progress
Embecta (Nasdaq:EMBC) shares rose this morning as it increased its full-year guidance and shared an update on its automated insulin delivery technology. The company also reported third-quarter results that came in ahead of the consensus forecast. Shares of EMBC ticked up 3.1% at $22.27 apiece in early-morning trading today. MassDevice’s MedTech 100 Index — which […]
